The Good The Bad And The Non-Quantifiable – A Comparison of Rebates on Orphan Drugs Versus Non-Orphan Drugs In Germany
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1357
https://www.valueinhealthjournal.com/article/S1098-3015(16)32723-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1276
First Page :
A582
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32723-1&doi=10.1016/j.jval.2016.09.1357